SCHEMBL2906895

SCHEMBL2906895

Nc1nc(NCCCn2cc(NC(=O)NCc3cccnc3)c(-c3ccc(Cl)cc3Cl)c2)ccc1[N+](=O)[O-]

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.47
GSK3B P49841 4/20 0.45
GSK3A P49840 3/20 0.45
CDK1 P06493 2/20 0.45
HTT P42858 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
CCNB2 O95067 1/20 0.43
CCNB1 P14635 1/20 0.43
CCNB3 Q8WWL7 1/20 0.43
NAMPT P43490 5/20 0.41
CDK5 Q00535 1/20 0.41
CDK5R1 Q15078 1/20 0.41
ATM Q13315 1/20 0.39
LMNA P02545 1/20 0.39
NPC1 O15118 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2903991 0.89 POLB (0.56) POLBGSK3BGSK3ACDK1HTT
SCHEMBL2912637 0.85 POLB (0.47) POLBGSK3BGSK3ACDK1HTT
SCHEMBL2904807 0.84 GSK3B (0.45) GSK3BGSK3ACDK1SMN1; SMN2CCNB2
SCHEMBL2904684 0.84 GSK3B (0.47) POLBGSK3BGSK3ACDK1HTT
SCHEMBL2910561 0.84 GSK3B (0.51) GSK3BGSK3ACDK1CCNB2CCNB1
SCHEMBL2910255 0.82 POLB (0.52) POLBGSK3BGSK3ACDK1HTT
SCHEMBL2910463 0.82 POLB (0.52) POLBGSK3BGSK3ACDK1HTT
SCHEMBL2909753 0.81 HPGD (0.47) POLBGSK3BGSK3ACDK1HTT
SCHEMBL2911856 0.81 GSK3B (0.52) GSK3BGSK3ACDK1SMN1; SMN2CCNB2
SCHEMBL2904255 0.81 GSK3B (0.47) POLBGSK3BGSK3ACDK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed